Compulsory licensing in copyrights, Al Hamd challenges PPL’s fees
This post examines Al Hamd Tradenation's challenge to PPL's license fee structure under Section 31 of the Copyright Act. The Delhi High Court has deferred a final decision,…
Compulsory Licensing
30 articles
After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more
Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO's decision on double patenting, updates from…
In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies
The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis…
Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more
The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government's approach to compulsory licensing of essential medicines.…
Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more
The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global…
Intellectual Property, Accessibility and Public health
This analysis explores the relationship between intellectual property, accessibility, and public health, with a focus on recent global developments amid COVID-19. It highlights key policy measures, compulsory licensing,…
Compulsory Licensing in India – Talk by Gaurav Mishra
Mr. Gaurav Mishra presented an in-depth session on compulsory licensing in India under the Patents Act at a DST Rajasthan event. The talk covered legal provisions, case studies,…
COVID crisis threatens Gilead’s patent on Remdesvir, EPO’s Enlarged Board of Appeal issues opinion on plant and animal patentability, India asks G20 to establish agreement enabling use of TRIPS flexibilities and other patent news
The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on…
The IP Choices We Make Today Will Shape our Tomorrow
This post discusses the crucial role of intellectual property choices during the COVID-19 crisis. It calls for balanced policies and open collaboration to foster innovation and ensure access…
Preference for Collaborative and Open COVID Innovation and Creativity
The post explores the preference for collaborative and open innovation during the COVID-19 crisis, detailing the decline in IP filings and the shift away from IP exclusivity. It…